Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome
Aurélien Delluc(University of Ottawa), P. Cacoub(Sorbonne Université), C. Françès(Navarre Institute of Health Research), Nicolas Limal(Assistance Publique – Hôpitaux de Paris), Xavier Puéchal(Université Paris Cité), J.C. Pietté(Sorbonne Université)
Cited by 69
Related Papers
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
|Arthritis & Rheumatism|2002|574
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Pacemaker infective endocarditis
|The American Journal of Cardiology|1998|314
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Skin Thickness Changes in Normal Aging Skin
|Gerontology|2009|258